Therapeutic Solutions International Inc (TSOI)

[ADVFN_curncman]

If the valuations of TSOI's subsidiaries reach a hypothetical $300 million soon, considering TSOI's market capitalization is $6 million, the combined value would be $306 million. With 3,800,000,000 shares outstanding, this translates to approximately $0.0805 per share.

However, it raises questions about the disparity between TSOI's market capitalization and the substantial valuations of its private subsidiaries, totaling nearly $300 million. Despite TSOI being the parent company and the majority owner of these subsidiaries, the market seems to undervalue it at only $6 million. This discrepancy suggests that either the public valuation is significantly underrated or the private valuations are overly optimistic.

An interesting observation is that CNSI, with its successive funding rounds and an anticipated Nasdaq IPO in 2024, projects a potential increase in the per-share price to $4 or $5. Considering TSOI's 40% ownership, this could lead to a substantial valuation, potentially reaching $195 million or $78 million after factoring in a 40% dividend. The market's neglect of these private holdings seems to create an intriguing valuation puzzle.